These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12673555)

  • 81. [Urothelial carcinomas of the upper tract: the myth became a reality].
    Rouprêt M; Colin P
    Prog Urol; 2014 Nov; 24(15):939-42. PubMed ID: 25195030
    [No Abstract]   [Full Text] [Related]  

  • 82. A clinical and molecular review of inverted papilloma of the urinary tract: how to handle?
    Jørgensen PH; Vainer B; Hermann GG
    APMIS; 2015 Nov; 123(11):920-9. PubMed ID: 26358542
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Urothelial cancers of the upper urinary tract: metastatic pattern and its correlation with tumor histopathology and location.
    Shinagare AB; Fennessy FM; Ramaiya NH; Jagannathan JP; Taplin ME; Van den Abbeele AD
    J Comput Assist Tomogr; 2011; 35(2):217-22. PubMed ID: 21412093
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Lynch syndrome in upper tract urothelial carcinoma: significance, screening, and surveillance.
    Pradere B; Lotan Y; Roupret M
    Curr Opin Urol; 2017 Jan; 27(1):48-55. PubMed ID: 27533503
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Preliminary evaluation of microsatellite instability in skin cancers].
    Rucińska M; Kozłowski L; Pepiński W; Skawrońska M; Janica J; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2002 Oct; 13(76):281-3. PubMed ID: 12557430
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Micropapillary urothelial carcinoma of the urinary tract.
    Humphrey PA
    J Urol; 2011 Sep; 186(3):1071-2. PubMed ID: 21784465
    [No Abstract]   [Full Text] [Related]  

  • 87. [Inverted papilloma of the pyelo-ureteral junction, current literature data].
    Manel A; Combe M; Devonec M
    Prog Urol; 2000 Apr; 10(2):282-6. PubMed ID: 10857148
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Urothelial inverted papilloma].
    Rodríguez-Rubio FI; Martín-Marquina A; Abad JI; Rosell D; Robles JE; Zudaire JJ; Berián JM
    Actas Urol Esp; 1995 Sep; 19(8):611-9. PubMed ID: 8669328
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Programmed cell death-ligand 1 expression in different molecular subtypes of upper tract urothelial carcinoma.
    Tomiyama E; Fujita K; Hashimoto M; Miyamoto H; Netto GJ; Nonomura N
    Int J Urol; 2022 Jan; 29(1):89-90. PubMed ID: 34519113
    [No Abstract]   [Full Text] [Related]  

  • 90. Discordance of HER2 expression in primary and recurrent/metastatic urothelial carcinoma in the upper tract.
    Ye J; Zhang M; Bao Y
    Asian J Surg; 2024 Sep; 47(9):3928-3929. PubMed ID: 38744655
    [No Abstract]   [Full Text] [Related]  

  • 91. A rare pure lymphoepithelioma-like carcinoma of the renal pelvis mimicking upper tract urothelial carcinoma: A potential diagnostic pitfall.
    Chen YC; Chen HW; Chueh KS; Wei YC
    Kaohsiung J Med Sci; 2018 Nov; 34(11):657-658. PubMed ID: 30392573
    [No Abstract]   [Full Text] [Related]  

  • 92. Molecular serological detection of DNA alterations in transitional cell carcinoma is highly sensitive and stage independent.
    von Knobloch R; Brandt H; Schrader AJ; Heidenreich A; Hofmann R
    Clin Cancer Res; 2004 Feb; 10(3):988-93. PubMed ID: 14871977
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Identical clonal origin of synchronous and metachronous low-grade, noninvasive papillary transitional cell carcinomas of the urinary tract.
    Li M; Cannizzaro LA
    Hum Pathol; 1999 Oct; 30(10):1197-200. PubMed ID: 10534167
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Diffuse inverted micropapillomatosis of the upper excretory tract. Apropos of a case. Review of the literature].
    Dahmani F; Abourachid H; Locquet P; Quenum C; Daher N; Levan L
    J Urol (Paris); 1986; 92(6):353-9. PubMed ID: 3540133
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Role of chemotherapy in upper urinary tract urothelial cell cancers.
    Kwan A; Mazhar D
    Future Oncol; 2011 Sep; 7(9):1067-75. PubMed ID: 21919694
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comparison of Fibroblast Growth-factor Receptor Gene Alterations at the DNA versus Messenger RNA Level in Advanced Urothelial Cancer: Insights for Clinical Research.
    Necchi A; Raggi D; Volpi CC; Giannatempo P; Colecchia M; Gloghini A
    Eur Urol Focus; 2019 Jul; 5(4):689-692. PubMed ID: 28855072
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Evaluation of upper urinary tract tumors with portal venous phase MDCT: a case-control study.
    Kupershmidt M; Margolis M; Jang HJ; Massey C; Metser U
    AJR Am J Roentgenol; 2011 Aug; 197(2):424-8. PubMed ID: 21785089
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Uro-CT protocol for the diagnosis of small urothelial neoplasms of urinary tract by quantitative analysis of contrast enhancement and correlation to the histological grading].
    Capasso R; Rossi C; Russo A; D'Andrea A; La Porta M; Cesarano E; Antinolfi G; Fonio P; Brunese L
    Recenti Prog Med; 2013; 104(7-8):406-8. PubMed ID: 24042417
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Exceptional Response on Addition of Everolimus to Taxane in Urothelial Carcinoma Bearing an NF2 Mutation.
    Ali SM; Miller VA; Ross JS; Pal SK
    Eur Urol; 2015 Jun; 67(6):1195-1196. PubMed ID: 25630452
    [No Abstract]   [Full Text] [Related]  

  • 100. The Lynch syndrome II and urological malignancies.
    Lynch HT; Ens JA; Lynch JF
    J Urol; 1990 Jan; 143(1):24-8. PubMed ID: 2294255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.